BUTORFANOL (Butorphanolum) * (-) -17 - (Tsiklobutilmetil) - morfinan-3, 14-diol.

     Synonyms : Moradol, Moradol, Stadol, Torate, Torbugesic, Torgesic, Torbutrol, Verstadol.

     Butorphanol is a strong analgetikom for parenteral use. Refers to a group antagonistov- opioid receptor agonists and is close in this respect to pentazotsinu and nalbufinu. For potency, speed and duration of the effects of close to morphine, but is effective in smaller doses than morphine; Butorfanola dose of 2 mg is a strong analgeziyu. Relatively with morphine has low potential narkogennym less potential to cause physical dependence.

     Butorphanol applied mainly to the strong pain : the aftercare period, the cancer patients with kidney cramps, severe trauma, etc.

     Enter intramuscularly or intravenously. Regular single dose for adults intramuscularly 2 mg every 4 hours (1 to 4 mg, depending on the intensity of pain). Regular single intravenous dose of 1 mg (from 0.5 to 2 mg) every 3 to 4 hours

     In practice anaesthetics used for sedation during the operation and aftercare period. To enter sedation intramuscularly in the 2 mg dose for 30-60 minutes prior to the operation. During the operation the injected dose of 2 to 4 mg, if necessary, an additional 2 mg for a total dose of 4 - 12, 5 mg (0.06 - 0.18 mg / kg). Butorphanol, can be used in smaller doses (1, 2 mg) of <<political mix "- coupled with diprazinom, atropine.

     For cancer patients applied intramuscularly in one-time dose of 2 mg daily dose of 2 and 24 mg.

     In applying butorfanola possible respiratory depression about the same as in the admission of morphine (in ekvieffektivnyh doses), drowsiness, dizziness, weakness, sweating, nausea. There is increasing pressure in the pulmonary artery and systolic blood pressure, increased heartbeat, increased vnutricherepnogo pressure. Perhaps there urticaria.

     Butorphanol should be used with caution in respiratory failure, cranial cerebral injury, a violation of liver and kidney function. Caution must be exercised in patients with high blood pressure.

     Do not nominate drug to patients under the age of 18 years (due to the lack of experience of studying the drug in children and adolescents).

     It should appoint a drug to patients with physical dependence on drugs.

     Product : in 1 ml ampoules containing 0,002 grams (2 mg) butorfanola tartrate, in a package of 50 pieces.

     Storage : using the drug store analgetikov.

Materials allowed to copy only with the active hyperlink to the handbook of medicines